9 Amendments of Mick WALLACE related to 2020/2071(INI)
Amendment 2 #
Draft opinion
Recital A
Recital A
A. whereas the problem of medicine shortages in the Member States is getting ever more severe on account of the lack of production capacity in the EU and the relocation of our industries in the sector to other markets in third countries and the artificial shortage created by pharmaceutical companies which choose to focus on profitability ;
Amendment 13 #
Draft opinion
Recital C
Recital C
C. whereas high safety standards and preservation of working conditions for transport workers should be guaranteed and whereas pharmaceutical regulation should ensure the quality, safety and efficiency of the supply of medicines between Member States;
Amendment 58 #
Draft opinion
Paragraph 5
Paragraph 5
5. Notes the importance of guaranteeing high safety standards for both transport infrastructure and employees, making it possible to manage significant volumes in the supply chain without disruptions or posing risks to health; stresses the need to preserve the working conditions established before the crisis in terms of working time and rest and to privilege branch agreements for any modification of the working conditions required by the supply continuity;
Amendment 74 #
Motion for a resolution
Recital B a (new)
Recital B a (new)
Ba. whereas two billion people worldwide do not have access to basic medicines;
Amendment 133 #
Motion for a resolution
Recital E a (new)
Recital E a (new)
Ea. whereas the Commission made 63 demands to individual Member States that governments cut spending on healthcare and/or outsource or privatise health services between 2011-2018 through the European Semester;
Amendment 456 #
Motion for a resolution
Paragraph 11
Paragraph 11
11. Stresses the importance of research and innovation, and calls for the establishment of a genuine European network, given that the price of relocation must not be a deterioration in the quality of medical research; calls for assurances that public investment in research and development will not lead to privatised solutions;
Amendment 467 #
Motion for a resolution
Paragraph 11 a (new)
Paragraph 11 a (new)
11a. Calls for reform of the TRIPS agreement so poor countries can have equitable and affordable access to the technologies and medicines they need; calls for public health medicines to be exempt from the patent system to ensure that poor countries have the legal right to produce and import generic versions of life-saving medicines;
Amendment 669 #
Motion for a resolution
Paragraph 18 a (new)
Paragraph 18 a (new)
18a. Considers it essential to abandon the public-private partnership model for the development of medicines and to sufficiently fund public research in medicines for the public good;
Amendment 673 #
Motion for a resolution
Paragraph 18 b (new)
Paragraph 18 b (new)
18b. Calls for the abandonment of the Stability and Growth Pact, which has impeded Member States from properly funding their health services, has driven the privatisation agenda, and contributed to the disastrous response of the EU to the COVID-19 pandemic;